Search Results:  KWMN — Women Issues  (6)

  • Statement from the first ACT-Accelerator Facilitation Council meeting

    We acknowledge the urgency of catalysing a step-change in political support and financing for the ACT- Accelerator in order to enable it to deliver on its mission of accelerating the discovery and deployment of new COVID-19 tools to all people, everywhere.

    Roles: Everyone: All Users

    Regions: Norway , South Africa

    Topics: Coronavirus (COVID-19), Global Health

  • GDG Virtual Meeting on the update of the Consolidated Guidelines for use of antiretrovirals for preventing and treating HIV infection

    WHO has made available the membership of the Guidelines Development Group (GDG) for the update of the WHO "Consolidated Guidelines for use of antiretrovirals for preventing and treating HIV infection."

    Roles: Everyone: All Users

  • Target product profiles for tuberculosis preventive treatment

    The World Health Organization (WHO) has launched target product profiles to drive the rapid development of novel tuberculosis (TB) preventive treatment today. The target product profiles characterise the most important product attributes to be considered for developing the best suited TB prevention treatments in future.

    One quarter of the global population is estimated to be infected with TB and are at greater risk of developing TB disease, especially those with weakened immunity. Treatment of T

    Roles: Everyone: All Users

    Regions: Canada , France , Italy , United Kingdom

    Topics: Global Health

  • World Hepatitis Day: fast-tracking the elimination of hepatitis B among mothers and children

    On World Hepatitis Day 2020, WHO is calling for united and stepped-up action to prevent mother-to-child transmission of hepatitis B (HBV), a preventable viral infection that attacks the liver and claims the lives of nearly 900 000 people each year.

    Roles: Everyone: All Users

    Topics: Coronavirus (COVID-19), Global Health

  • European Medicines Agency (EMA) approval of the dapivirine ring for HIV prevention for women in high HIV burden settings

    The European Medicines Agency announced today that its human medicines committee provided a positive benefit-risk opinion on the use of the Dapivirine Vaginal Ring (DPV-VR) for HIV prevention. WHO stresses that when providing HIV prevention for women it is always critical to provide these alongside other services including STI diagnosis and treatment, HIV testing and links to antiretroviral therapy for all women who test positive and a range of contraception options.

    Roles: Everyone: All Users

    Regions: Kenya

    Topics: Global Health, Global Women's Issues

  • New COVID-19 Law Lab to provide vital legal information and support for the global COVID-19 response

    Launching today, the COVID-19 Law Lab initiative gathers and shares legal documents from over 190 countries across the world to help states establish and implement strong legal frameworks to manage the pandemic. The goal is to ensure that laws protect the health and wellbeing of individuals and communities and that they adhere to international human rights standards.

    The new Lab (at www.COVIDLawLab.org) is a joint project of United Nations D

    Roles: Everyone: All Users

    Regions: United Kingdom

    Topics: Climate and Environment, Combating Drugs and Crime, Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Global Health, Human Rights and Democracy, Science, Technology, and Innovation

Results 1 - 6 of 6

  • Regions









































































































































































































































  • Topics